An OVID Health article by Shamilah Nyiramukwaya Last week, I told you I was going to the World #EPACongress to find the colleagues we need to bring along on the patient engagement journey, wherever they are. Well. I went. I listened. And here are the reflections I brought back. 1. Value must be reframed, and …
An OVID Health article by Sophie Feary Thoughts from my time in Basel at health.tech | global summit When people think of Basel, they picture pharma giants and I don’t blame them. From my hotel window, the Roche tower dominates the skyline, and the Novartis campus defines one side of the city. But for a …
An OVID Health article by Shamilah Nyiramukwaya I spent two days at the Patient Centricity and Collaboration World Conference Europe in London last week. Brilliant conversations, engaging speakers, and a lot to sit with. But the thing I keep returning to is not a session or a statistic. It’s who was not in the room. …
An OVID Health article by David Talbot In a world of AI, it was refreshing to bring together a cohort of genuine experts in oncology policy, science and innovation to discuss & debate – in detail – the National Cancer Plan: The plan represents the government’s most comprehensive and ambitious cancer strategy in over a …
As our CEO Jenny Ousbey headed to the in Dubai, it was an ideal moment to take stock of the MedTech shifts shaping 2026 and why this year feels like a turning point for adoption over innovation. AI is no longer the story, implementation is AI-enabled diagnostics, decision-support tools and remote monitoring are now widely used, …
An OVID Health article by Ollie George Yesterday the UK Government announced a landmark UK-US pharmaceutical trade deal designed to safeguard medicines access and reinforce the UK’s position as a life sciences superpower. The deal delivers headline commitments that have been widely welcomed by industry: · Zero tariffs on pharmaceutical exports · A reduced VPAG …
The OVID team were proud to support Tillotts Pharma UK in launching the A Chronic Cost campaign in Parliament yesterday. Hosted by Baroness Young of Old Scone, the event shone a spotlight on the impact of prescription charges on people living with inflammatory bowel disease (IBD) in England. Featuring powerful insights from the IBD community, …
An OVID Health article by Anna Parnanen Recently, the Cell and Gene Therapy Catapult and the Advanced Therapy Treatment Centre (ATTC) network brought the ATMP community together for “Shaping a stronger UK ecosystem for advanced therapy clinical trials.” OVID Health acts as a secretariat to the Cell and Gene Collective (CGC), an alliance of five …
An OVID Health article by Shamilah Nyiramukwaya “We are people and we are partners.” This powerful statement, shared at the Patient Empowerment World Congress 2025, captured the shift many of us have been waiting for: moving beyond the language of “patient centricity” toward genuine empowerment. For two days, pharma leaders, regulators, clinicians, advocates, and digital …
An OVID Health article by Jen Mannion I recently had the opportunity to speak with two of the key figures at King’s College London’s Centre for Pharmaceutical Medicine Research, Dr Liz Clark and Professor Graham McClelland. Patient engagement forms one of the Centre’s central three research themes and is integrated throughout its teaching. At a …
We’re an award-winning global specialist healthcare communications consultancy, creators of the Patient Advocacy & Centricity Tracker tool and founders of the global Patient Partnership Index.
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
